Form 8-K - Current report:
SEC Accession No. 0000950170-25-087696
Filing Date
2025-06-18
Accepted
2025-06-18 08:30:50
Documents
10
Period of Report
2025-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K cadl-20250617.htm   iXBRL 8-K 60762
  Complete submission text file 0000950170-25-087696.txt   174192

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT cadl-20250617.xsd EX-101.SCH 26968
12 EXTRACTED XBRL INSTANCE DOCUMENT cadl-20250617_htm.xml XML 5112
Mailing Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494
Business Address 117 KENDRICK STREET SUITE 450 NEEDHAM MA 02494 617-916-5445
Candel Therapeutics, Inc. (Filer) CIK: 0001841387 (see all company filings)

EIN.: 522214851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40629 | Film No.: 251055229
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)